Cara Therapeutics investor relations material

Listen to the latest call from Cara Therapeutics

Cara Therapeutics, Inc. is a biopharmaceutical company that focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States.

  • Ticker

  • Country


Dig deeper into the Cara Therapeutics fundamentals on Quartr.